The next phase in Long COVID research: addressing the ethical challenges in trials of disease-modifying treatments.
Saved in:
| Title: | The next phase in Long COVID research: addressing the ethical challenges in trials of disease-modifying treatments. |
|---|---|
| Authors: | Hendriks S; Department of Bioethics, Clinical Center, National Institutes of Health, Bethesda, MD, USA., Grady C; Department of Bioethics, Clinical Center, National Institutes of Health, Bethesda, MD, USA., Fitzgerald ML; Brain Inflammation Collaborative, Inc., Delafield, WI, USA.; Patient Led Research Collaborative, Calabasas, CA, USA., Gross RS; Division of General Pediatrics, Department of Pediatrics, Department of Population Health, NYU Grossman School of Medicine, New York, USA., Maughan C; Utah Covid-19 Long Haulers, Salt Lake City, UT, USA., Peluso MJ; Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, San Francisco, CA, USA., Varma S; Independent Scholar., Nath A; Section of Infections of the Nervous System, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA., Rid A; Department of Bioethics, Clinical Center, National Institutes of Health, Bethesda, MD, USA.; Fogarty International Center, National Institutes of Health, Bethesda, MD, USA. |
| Source: | EClinicalMedicine [EClinicalMedicine] 2026 May 07; Vol. 95, pp. 103918. Date of Electronic Publication: 2026 May 07 (Print Publication: 2026). |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: The Lancet Country of Publication: England NLM ID: 101733727 Publication Model: eCollection Cited Medium: Internet ISSN: 2589-5370 (Electronic) Linking ISSN: 25895370 NLM ISO Abbreviation: EClinicalMedicine Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42163969 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: The next phase in Long COVID research: addressing the ethical challenges in trials of disease-modifying treatments. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Hendriks+S%22">Hendriks S</searchLink>; Department of Bioethics, Clinical Center, National Institutes of Health, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Grady+C%22">Grady C</searchLink>; Department of Bioethics, Clinical Center, National Institutes of Health, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Fitzgerald+ML%22">Fitzgerald ML</searchLink>; Brain Inflammation Collaborative, Inc., Delafield, WI, USA.; Patient Led Research Collaborative, Calabasas, CA, USA.<br /><searchLink fieldCode="AU" term="%22Gross+RS%22">Gross RS</searchLink>; Division of General Pediatrics, Department of Pediatrics, Department of Population Health, NYU Grossman School of Medicine, New York, USA.<br /><searchLink fieldCode="AU" term="%22Maughan+C%22">Maughan C</searchLink>; Utah Covid-19 Long Haulers, Salt Lake City, UT, USA.<br /><searchLink fieldCode="AU" term="%22Peluso+MJ%22">Peluso MJ</searchLink>; Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Varma+S%22">Varma S</searchLink>; Independent Scholar.<br /><searchLink fieldCode="AU" term="%22Nath+A%22">Nath A</searchLink>; Section of Infections of the Nervous System, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Rid+A%22">Rid A</searchLink>; Department of Bioethics, Clinical Center, National Institutes of Health, Bethesda, MD, USA.; Fogarty International Center, National Institutes of Health, Bethesda, MD, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101733727%22">EClinicalMedicine</searchLink> [EClinicalMedicine] 2026 May 07; Vol. 95, pp. 103918. <i>Date of Electronic Publication: </i>2026 May 07 (<i>Print Publication: </i>2026). – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article; Review – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22The+Lancet%22">The Lancet </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101733727 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2589-5370 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2225895370%22">25895370 </searchLink><i>NLM ISO Abbreviation: </i>EClinicalMedicine <i>Subsets: </i>PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42163969 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.eclinm.2026.103918 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 103918 Titles: – TitleFull: The next phase in Long COVID research: addressing the ethical challenges in trials of disease-modifying treatments. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Hendriks S – PersonEntity: Name: NameFull: Grady C – PersonEntity: Name: NameFull: Fitzgerald ML – PersonEntity: Name: NameFull: Gross RS – PersonEntity: Name: NameFull: Maughan C – PersonEntity: Name: NameFull: Peluso MJ – PersonEntity: Name: NameFull: Varma S – PersonEntity: Name: NameFull: Nath A – PersonEntity: Name: NameFull: Rid A IsPartOfRelationships: – BibEntity: Dates: – D: 07 M: 05 Text: 2026 May 07 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2589-5370 Numbering: – Type: volume Value: 95 Titles: – TitleFull: EClinicalMedicine Type: main |
| ResultId | 1 |
